Created by on 03/14/2011

On March 3rd, the Federation of American Societies for Experimental Biology (FASEB) released a new data compilation detailing National Institutes of Health (NIH) funding trends from FY 1995-2012 that spotlights the financial crisis threatening progress in biomedical research. A statement accompanying the slide set described the dire situation facing the agency, which does not have sufficient funds to support all of the critical opportunities available today. Citing data from the report, FASEB President William T. Talman commented in a press release that “in a time of unprecedented scientific opportunity, it is discouraging that the number of grants funded by NIH is actually decreasing.”


Talman further warned that “This dire situation will become even more devastating if the proposed cuts to the NIH budget contained in HR 1 are enacted.” He also wrote a letter to all members of the Senate urging them to reject the House version of the continuing resolution for fiscal year 2011, explaining that “cutting back on our investment in NIH would harm individuals in every state by delaying research that can lead to cures and slowing the discovery of new treatments for costly illnesses.” In addition, the letter noted that reducing the NIH budget by $1.6 billion this year will slow the discovery of new treatments, lead to wasteful termination of projects, discourage young people from pursuing careers in science, and ultimately cost some Americans their jobs.